eprintid: 10146418
rev_number: 12
eprint_status: archive
userid: 699
dir: disk0/10/14/64/18
datestamp: 2023-01-09 15:19:47
lastmod: 2023-01-09 15:20:07
status_changed: 2023-01-09 15:19:47
type: conference_item
metadata_visibility: show
sword_depositor: 699
creators_name: Mo, Jiping
creators_name: Vickerstaff, Victoria
creators_name: Minton, Ollie
creators_name: Tavabie, Simon
creators_name: Taubert, Mark
creators_name: Stone, Paddy
creators_name: White, Nicola
title: How effective is virtual reality technology in palliative care? A systematic review and meta-analysis
divisions: C07
divisions: D79
divisions: B02
divisions: UCL
abstract: Introduction: Virtual Reality (VR) has the potential to alleviate common mental and physical health symptoms at the end-of-life. There is limited data on the efficacy of VR in palliative care. Aims To review the feasibility and effectiveness of VR intervention within a palliative care setting. / Method: Medline, Embase, AMED, PsycINFO, CINAHL, Cochrane Central Register of Controlled Trials and Web of Science were searched from inception up to March 2021. Studies that reported on the use of VR in an adult (over 18 years) palliative population were included. The ROB-2 (for RCTs) and ROBINS tools (for non-RCTs) were used to assess risk of bias. The GRADE tool assessed the quality of the evidence. Data regarding feasibility, acceptability, and changes of psychological and physical symptoms of palliative care patients were extracted. Standardised mean differences (Hedges’ g) were calculated from the pre- post data reported on patient outcomes. A DerSimonian-Laird random effects model meta-analysis was conducted. PROSPERO (CRD42021240395, 03/03/2021). / 
Results: 524 studies were identified; 8 studies were included, 5 were
included in the meta-analysis. All studies had at least some
concern for risk of bias. 44% (97/219) of patients were male; the
mean age ranged from 47 to 85 (years). Recruitment was feasible
and retention rates ranged between 55% and 100%. Discomfort
and technical issues were recorded in 4/7 studies (57%) but overall,
participants reported a positive experience. The meta-analysis
showed VR statistically significantly improved pain (p=0.0363),
tiredness (p=0.0030), drowsiness (p=0.0051), shortness of breath
(p=0.0284), depression (p=0.0091), and psychological well-being
(p=0.0201). The quality of the evidence was graded as low to very
low. / 
Conclusion: VR in palliative care is feasible and acceptable. Larger trials with a
control arm are needed.
Impact VR could be an adjuvant non-pharmacological therapy for
symptoms such as anxiety, pain, or depression. Higher quality
studies are needed to inform clinical recommendations.
date: 2022-02-02
date_type: published
official_url: https://www.mariecurie.org.uk/research/annual-research-conference
oa_status: green
full_text_type: other
language: eng
primo: open
primo_central: open_green
verified: verified_manual
elements_id: 1947716
lyricists_name: White, Nicola
lyricists_id: NWHIT30
actors_name: White, Nicola
actors_id: NWHIT30
actors_role: owner
full_text_status: public
pres_type: presentation
event_title: Marie Curie Research Conference 2022
event_location: Virtual conference
event_dates: 30 January - 04 February 2022
citation:        Mo, Jiping;    Vickerstaff, Victoria;    Minton, Ollie;    Tavabie, Simon;    Taubert, Mark;    Stone, Paddy;    White, Nicola;      (2022)    How effective is virtual reality technology in palliative care? A systematic review and meta-analysis.                   Presented at: Marie Curie Research Conference 2022, Virtual conference.       Green open access   
 
document_url: https://discovery.ucl.ac.uk/id/eprint/10146418/1/N.White%20Virtual%20Reality.%20Wednesday%202nd%20Feb.pdf